血淋巴细胞中的β-肾上腺素能受体变化与药物反应性改变。 - Suppr

Suppr

超能文献

Beta-adrenoceptor changes in blood lymphocytes and altered drug responsiveness.

作者信息

Brodde O E, Wang X L

机构信息

Biochem. Forschungslabor, Medizinische Klinik, Abteilung für Nieren- und Hochdruckkranke, Universität Essen, FRG.

出版信息

Ann Clin Res. 1988;20(5):311-23.

PMID:2905876

Abstract

摘要

相似文献

Beta-adrenoceptor changes in blood lymphocytes and altered drug responsiveness.血淋巴细胞中的β-肾上腺素能受体变化与药物反应性改变。

Ann Clin Res. 1988;20(5):311-23.

Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.普萘洛尔给药后人体淋巴细胞中β-肾上腺素能受体密度的升高。

J Clin Invest. 1980 May;65(5):949-57. doi: 10.1172/JCI109781.

Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria.人类、大鼠、豚鼠和兔心房中的β-肾上腺素能受体亚型。

J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1216-21.

Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.人类心脏β-肾上腺素能受体：通过“亲和状态”和多态性实现β1-肾上腺素能受体多样化

Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1020-8. doi: 10.1111/j.1440-1681.2007.04730.x.

Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.胆囊收缩素（CCK - 33）及其C末端片段：CCK - 8和CCK - 4与α和β肾上腺素能受体激动剂及拮抗剂在大鼠心血管系统中的相互作用。A部分

Pol J Pharmacol. 1998 May-Jun;50(3):203-12.

Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.塞利洛尔，一种强效的心脏选择性β1肾上腺素能受体拮抗剂，具有轻度的α2肾上腺素能受体拮抗特性。

J Hypertens Suppl. 1985 Dec;3(3):S195-7.

Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.参与心脏调节的心脏内在神经元具有α1、α2、β1和β2肾上腺素能受体。

Can J Cardiol. 1997 Mar;13(3):277-84.

The effect of beta-receptor stimulation on the activity of the inhibitor of cAMP-dependent protein kinase.β受体刺激对环磷酸腺苷依赖性蛋白激酶抑制剂活性的影响。

Acta Physiol Pol. 1981 Sep-Oct;32(5):501-6.

The pharmacological characterization of beta-sympathicolytic substances.

Indian Heart J. 1972 Jun;24:Suppl 1:146-56.

Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.90天尾部悬吊后心肌α1 - 而非β - 肾上腺素能受体的调节

J Gravit Physiol. 1996 Apr;3(1):57-62.

引用本文的文献

Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.β-肾上腺素能受体阻滞剂治疗与慢性心力衰竭中的心脏β-肾上腺素能受体-G蛋白-腺苷酸环化酶系统

Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):361-72. doi: 10.1007/s00210-006-0125-7. Epub 2007 Jan 11.

Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.卡替洛尔的β2肾上腺素能受体介导的内在拟交感活性：一项体内研究。

Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):361-8. doi: 10.1007/s00210-004-0988-4. Epub 2004 Oct 23.

Subtype-selective up-regulation of human saphenous vein beta 2-adrenoceptors by chronic beta-adrenoceptor antagonist treatment.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Apr;339(4):479-82. doi: 10.1007/BF00736065.

Effect of calcium and beta-adrenoceptor antagonists on beta-adrenoceptor density and Gs alpha expression in human atria.钙和β-肾上腺素能受体拮抗剂对人心房β-肾上腺素能受体密度及Gsα表达的影响。

Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):171S-173S. doi: 10.1111/j.1365-2125.1990.tb05497.x.

Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.慢性β-肾上腺素能受体拮抗剂治疗对人心肌β-肾上腺素能受体和毒蕈碱受体的差异调节

Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):112S-114S. doi: 10.1111/j.1365-2125.1990.tb05478.x.

Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.

Eur J Clin Pharmacol. 1990;39(5):447-51. doi: 10.1007/BF00280934.

Lack of effect of chronic calcium antagonist treatment on beta 1- and beta 2-adrenoceptors in right atria from patients with or without heart failure.慢性钙拮抗剂治疗对伴或不伴心力衰竭患者右心房β1和β2肾上腺素能受体无影响。

Br J Clin Pharmacol. 1992 Mar;33(3):269-74. doi: 10.1111/j.1365-2125.1992.tb04034.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验